New fee structure for the academic year 2022-23 has been updated. Please click here to know more     B.Pharm program is internationally accredited by Accreditation Council for Pharmacy Education (ACPE), USA. Please click here to know more     All Programs are accredited by Ministry of Education, UAE.    All our programs are recognized by the kingdom of Saudi Arabia.    CIRCULAR : COVID-19 Vaccination Update for all the new students    RAK College of Medical Sciences is listed in the World Directory of Medical Schools(WDOMS)

RAK MHSU Banner image
Dr. Sirajunisa Talath Profile Picture

Dr. Sirajunisa Talath

Associate Professor

Educational Qualification:
  • Ph. D. (Pharmaceutical Chemistry) Rajiv Gandhi University of Health Sciences, Karnataka, Bangalore, India (August 2007)
  • M. Pharm. (Pharmaceutical Chemistry) Rajiv Gandhi University of Health Sciences, Karnataka, Bangalore, India (March 2002)
  • Bachelor of Pharmacy Gulbarga University, Gulbarga, India, (July 1997)
Professional Career:
  • Associate Professor, Department of Pharmaceutical Chemistry, RAK College of Pharmaceutical Sciences, RAK Medical and Health Sciences University, Ras Al Khaimah, UAE (November 2017-Present)
  • Assistant Professor, Department of Pharmaceutical Chemistry, RAK College of Pharmaceutical Sciences, RAK Medical and Health Sciences University, Ras Al Khaimah, UAE (October 2009-October 2017)
  • Associate Professor, Department of Pharmaceutical Chemistry, RMES’s College of Pharmacy, Gulbarga, Karnataka, India (September 2007-October 2009)
  • Assistant Professor, Department of Pharmaceutical Chemistry at NGSM Institute of Pharmaceutical Sciences, Mangalore, Karnataka, India (October, 2005 – August 2007)
  • Lecturer in Pharmaceutical Chemistry at Luqman College of Pharmacy, Gulbarga-2, Karnataka. (November 1997-January 2000)
Achievements/ Interests/Publications/Awards:

No of Publications: 17

Patents: 01

Patents: 

  1. Bhoomendra A. Bhongade, Sirajunisa Talath. Chiral imidazo[2,1-b][1,3,4]thiadiazole compounds and processes for synthesizing the same. Indian Patent No 373257, July 29, 2021

Patent Filed

  1. Sirajunisa Talath and Andanappa K. Gadad. Substituted 2-Anilinonicotinic acids and their use in inflammatory conditions. Indian Patent Application No 1114/CHE/2004 (Published 27th Oct 2006). 

Research articles:

  • Sirajunisa Talath, Syeda Humaira. Validated Stability-Indicating RP-HPLC Method for the Determination of Norfloxacin in Pharmaceutical Dosage Form. Journal of Biomedical and Pharmaceutical Research. 2021; Vol 10 (4). DOI: 10.32553/jbpr.v10i4.873
  • Sirajunisa Talath, Shaikh Gazi. A Validated Stability-Indicating Method for the Estimation of Aceclofenac in Pharmaceutical Dosage Form by RP-HPLC. Am. J. PharmTech Res. 2020; 10(4): 179-196. DOI:10.46624/ajptr.2020.v10.i4.016
  • Bhoomendra A. Bhongade, Sirajunisa Talath, Ravikiran A. Gadad, Andanappa K. Gadad. Biological activities of imidazo[2,1-b][1,3,4]-thiadiazole derivatives: A review. J Saudi Chem Soc (2016) 20, S463-S475
  • Bhoomendra Bhongade, Sirajunisa Talath and Sunil Dhaneshwar, A Validated Method for the Quantitation of Ciprofloxacin Hydrochloride Using Diffuse Reflectance Infrared Fourier Transform Spectroscopy. International Journal of Spectroscopy Vol 2014, http://dx.doi.org/10.1155/2014/294612.
  • Sirajunisa Talath, Pramod J. Shirote, W. John Lough, Andanappa K. Gadad. Stability Studies of Some Glycolamide Ester Prodrugs of Niflumic Acid in Aqueous Buffers and Human Plasma by HPLC with UV Detection. Arzneimittelforschung 2006; 56(9): 631-639. DOI: 10.1055/s-0031-1296764 
Conferences/Workshops:
  • Workshops (Attended) - 12
  • Seminars (Attended) -  28
  • Conferences (Participated) -35
  • Conferences (Paper presented) - 22
  • Conferences/ Seminars (Conducted) -  07